Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization - Wikidata - thesis-toulmin - TriplyDB

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

http://www.wikidata.org/entity/Q27484661

about

P1343

Mechanism and significance of cell type-dependent neutralization of flaviviruses Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody Dengue virus markers of virulence and pathogenicity Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Dissecting the human serum antibody response to secondary dengue virus infections A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka.In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.Utility, limitations, and future of non-human primates for dengue research and vaccine development The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus.Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010.Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA A novel reporter system for neutralizing and enhancing antibody assay against dengue virus A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development.Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.Unsuspected dengue and acute febrile illness in rural and semi-urban southern Sri Lanka Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

P2860

Q54973776-BAC3C7BD-7546-4FF0-B9E6-FA9B103B5886

P1343

Q23032973-AFD46B6B-37A3-4310-AA42-E2E5EAEC7144 Q26257542-78E95EFD-4553-47A3-B4A9-05943EC59D5D Q27315772-BB663B4C-2739-4151-9677-EECC55F42F14 Q27489654-2FBA0B6A-E3A7-443D-BD96-AAA9A3BBDD92 Q27490922-7B0F853A-B82F-491C-91C9-38BE71367B28 Q27491299-1B0E41FD-D6CC-4E30-805E-512AC7A8D06B Q27493140-A075D62A-2CED-4908-BB2D-84BAE66DC400 Q27681319-D6F79F42-9AE0-456A-BB43-01462DE54453 Q28114614-414D5421-33B8-4FCF-AD20-19EDB72431CA Q28742961-B6E981E1-E6E3-4AF6-832D-360CF22C623A Q29051494-E2848712-CA79-49BC-9CCB-F8F81F2899E2 Q30395028-55EAC208-6CF2-459F-8FB8-D04BD99E9BCA Q33728716-A8CFBD19-EC0B-4154-AE8E-3A6C1A2F9531 Q33825684-A17056B7-1822-44A7-B2B3-34C0D3B79B59 Q33841059-D84355CB-7DCF-4AAF-8885-B01F8AA9FDBD Q33945441-77BC999D-F624-4BDC-B117-4FD52F3840CA Q34117580-C7612BAB-BECB-4B33-872A-F77124654D08 Q34184711-E5C97009-B650-4478-9941-55C121C32526 Q34184747-7CC46456-B9A5-4D95-A92F-61DCDC24BE02 Q34238916-C22875EC-ACD2-48C4-94DE-049EE1D8C4AF Q34386384-803E26E1-A4DA-4BCB-AAF8-1D1863BAC039 Q34426711-13B25ABF-5E5A-41CE-ACBF-3443791CB285 Q34593818-B609C0EA-7FE2-467A-97A9-3E5295A08595 Q34607919-60F4C458-7003-453A-903F-59FA34FDBEF6 Q34746139-AF133E9F-7A8F-4229-911B-F8947787CBA0 Q34778121-395304E8-8BF0-4E14-8A35-0AEBF4BDC89A Q35006549-427328A3-2B2A-4504-A745-A0D6A64FEE0B Q35081258-86BBDB69-F5A2-4094-BE37-A3BECA51DCB0 Q35096730-4A350B32-359A-45CF-8079-559C3487AB2A Q35138111-837AB826-F8AC-4942-ABEB-2FE6C048740A Q35195545-23EAE6FC-B607-4FC6-BB11-2D59E1906CAB Q35221318-8DE501AA-064D-416F-8DFC-CAC35417B56C Q35268996-7BD5E074-1BE8-4490-82BE-9AE32400DE4A Q35659085-EBFA554D-215A-40AD-A0E5-0CFDB99C7972 Q35666226-C6550F80-03F0-4441-B470-13CB3FBDB767 Q35701686-8C4C7B29-86CF-4425-A896-1AC40010CE5A Q35846987-364A2755-2F61-4C8B-A36B-3E55B396967E Q35915029-7A3049B6-1034-42C6-85BC-00409997DBE9 Q35919750-5AD7DE58-E200-4128-B538-B2231E4D15F6 Q35982791-125E40E2-5751-4E26-84E2-126331AAF1A2

P2860

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

http://www.wikidata.org/entity/Q27484661

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@ast

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@en

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@nl

type

label

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@ast

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@en

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@nl

prefLabel

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@ast

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@en

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@nl

P1433

Q27484661-EC651A10-1CD6-40D8-A340-F5E64D5448F6

P1476

Q27484661-BC33E747-6150-4406-A79D-B367178C5EE1

P2093

Q27484661-945D4651-DD03-4F35-8B3C-639948D479A5

Q27484661-E7B4A138-64E4-4B68-B1D6-E3F259462D28

Q27484661-EBEEF8D1-D062-4CE1-ACF5-0C988C71A836

P2860

Q27484661-055B2418-09A0-4333-8F0A-84516810653C

Q27484661-217FFF9C-E832-42CD-B957-BD9688BEF92E

Q27484661-2657AE3B-0CA5-42B6-977E-1C90ED97B5E5

Q27484661-377773D1-BD04-444E-84BF-5D11C119BFEB

Q27484661-4B28156E-BB01-4979-B7A2-F59F35C310D4

Q27484661-62BA9341-F5EE-4FAF-82C8-FF6AFA0D4629

Q27484661-6A4FB48B-FEF8-427F-9FE4-EFC2099A9B37

Q27484661-8268538D-3DB6-49C2-BB54-6994FFF17E0F

Q27484661-95CF7637-2E75-48E2-ABC8-82D19058D91F

Q27484661-A98C23C1-0044-4229-885E-38C264B19632

P304

Q27484661-07F79443-5268-4D67-BC65-0A57CC47CA22

P31

Q27484661-DDA2DDF4-B787-4AF6-81D6-6EF114D5A373

P3181

Q27484661-E8AD813F-AB9C-425B-A167-55777312AE07

P356

Q27484661-5423362E-9F4F-42D8-BD48-DA23373F7DAA

P407

Q27484661-12AE119F-B20B-499E-9CFC-5A17FB65D4B1

P433

Q27484661-F121B9C7-8FDB-4810-A2BB-931112895825

P4510

Q27484661-14892739-5753-4D29-8503-8676EA6E35B3

P478

Q27484661-463D073C-C542-47DF-B07A-1D83F4F67D49

P50

Q27484661-43604BDD-FFB8-4696-94E2-8F088266BF3C

P5008

Q27484661-8C4DE6D7-DAB0-44C6-9302-995B160CDC50

P577

Q27484661-1B45D3C8-6C17-45BD-B0AC-D582A39D07BF

P5875

Q27484661-F7A0572E-3EF0-4634-9372-E88EC6D7F502

P698

Q27484661-13616C8C-0FB1-486E-89CF-73ABBA828B20

P921

Q27484661-6626E0D1-A1A8-4EDB-96FA-6B4E0DA2483E

Q27484661-7A50B07A-1CEE-41C7-B5F8-5D039173AEC8

Q27484661-A73EFB57-55C6-46ED-81EE-B6C2D79248F7

P932

Q27484661-F63CC307-6C5B-4422-B8E3-E34546EF2F44

P3181

P356

P1433

Journal of Clinical Microbiology

P1476

Comparison of Plaque- and Flow ...... ng Dengue Virus Neutralization

@en

P2093

Annette A Kraus

http://www.w3.org/2001/XMLSchema#string

Laura B Haymore

http://www.w3.org/2001/XMLSchema#string

William Messer

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

The dengue viruses

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Flow cytometry-based assay for titrating dengue virus.

Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection

Understanding dengue pathogenesis: implications for vaccine design

Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants

Mechanisms of virus neutralization by antibody.

A variant in the CD209 promoter is associated with severity of dengue disease.

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.

P304

3777-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2889518

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JCM.00827-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P4510

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Aravinda de Silva

P5008

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6035200

http://www.w3.org/2001/XMLSchema#string

P698

17804661

http://www.w3.org/2001/XMLSchema#string

P921

P932

2168473

http://www.w3.org/2001/XMLSchema#string